Qualcomm Elects Dr. Susan Hockfield to Board of Directors

SAN DIEGO, July 10, 2012  /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced the election of Susan Hockfield, Ph.D., to its Board of Directors. Dr. Hockfield's career spans more than 30 years as a leader in biomedical science research, and she served as president of the Massachusetts Institute of Technology (MIT) until July 2012, where she also holds a faculty appointment as professor of neuroscience.

"We are fortunate to welcome Dr. Hockfield as a member of Qualcomm's Board of Directors," said Dr. Paul E. Jacobs, chairman and CEO of Qualcomm. "Her leadership experience in exploring new horizons in biomedical and energy research adds a unique perspective to our Board and complements Qualcomm's efforts to apply wireless technologies in fields such as healthcare and education."

Dr. Hockfield has distinguished herself both as a scientist and a leader of one of the world's premier science and engineering institutions. Following her university studies, Dr. Hockfield was a National Institutes of Health (NIH) postdoctoral fellow at the University of California at San Francisco, and then a member of the scientific staff of the Cold Spring Harbor Laboratory. Joining the faculty of Yale University in 1985, Dr. Hockfield's research focused on the development of the brain and on glioma, a deadly form of brain cancer, and pioneered the use of monoclonal antibody technology in brain research. At Yale, Dr. Hockfield emerged as a strong, innovative university leader, first as dean of its Graduate School of Arts and Sciences and later as provost, Yale's chief academic and administrative officer.

From December 2004 until July 2012, Dr. Hockfield served as the 16th president of MIT. The first woman and the first life scientist to lead MIT, Dr. Hockfield helped the university break new ground across a range of disciplines. Under her leadership, the university launched the MIT Energy Initiative in 2006, known as MITEI ("mighty"), a $350 million effort to accelerate research, policy and education to achieve a clean energy future. Dr. Hockfield championed breakthroughs emerging from the convergence of the life sciences with the engineering and physical sciences, in fields ranging from clean energy to cancer. Long an advocate for the research university as an engine of innovation and economic growth, Dr. Hockfield also worked to shape emerging national policy on energy technology and next-generation manufacturing.

Dr. Hockfield earned a Bachelor of Arts in biology from the University of Rochester and a Ph.D. from Georgetown University at the School of Medicine, while carrying out her dissertation research at the NIH.  She currently serves as an elected member of the American Academy of Arts and Sciences, and as a director of the General Electric Company, the Carnegie Corporation, the National Geographic and the World Economic Forum Foundation.  She holds honorary degrees from several U.S. and international universities.

About Qualcomm 

Qualcomm Incorporated (NASDAQ: QCOM) is the world leader in 3G and next-generation mobile technologies. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm's website, OnQ blog, Twitter and Facebook pages.

Qualcomm is a registered trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

SOURCE Qualcomm Incorporated



RELATED LINKS
http://www.qualcomm.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.